雜志介紹

Anticancer Research雜志介紹

《Anticancer Research》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)抗癌研究，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.6，最新CiteScore 指數(shù)為3.7。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Chalcone Derivatives Suppress Proliferation and Migration of Castration-resistant Prostate Cancer Cells Through FAK-mediated DNA Damage

  Author: Xiao, H. A. I. N. I. A. O.; Wu, Z. H. I. G. A. N. G.; Wang, Q. I. N. Q. U. A. N.; Zhou, C. H. A. O. F. E. N. G.; Lu, F. E. N. G.; Xiao, Y. U. N. B. E., I

• Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk

  Author: Liao, Cheng-hsi; Chang, Wen-shin; Hsu, Wei-lin; Hu, Pei-shin; Wu, Hsi-chin; Hsu, Shih-wei; Wang, Bo-ren; Yueh, Te-cheng; Chen, Chao-hsuan; Hsia, Te-chun; Huang, Wen-chin; Bau, Da-tian; Tsai, Chia-wen

• Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk

  Author: LI, Po-han; Liao, Cheng-hsi; Huang, Wen-chin; Chang, Wen-shin; Wu, Hsi-chin; Hsu, Shih-wei; Chen, Kai-yuan; Wang, Zhi-hong; Hsia, Te-chun; Bau, Da-tian; Tsai, Chia-wen

• Clinical Value of Magnetic Resonance Imaging Combined With Serum Prostate-specific Antigen, Epithelial Cadherin and Early Prostate Cancer Antigen 2 In Diagnosis of Prostate Cancer

  Author: Li, Kun; Luan, Qingxia; Zheng, Junze; Li, Ruidong; Li, Linkun; Sun, Yequan; Liu, Donghui

英文介紹

Anticancer Research雜志英文介紹

ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed.

ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).

Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.